Strontium ranelate 135459-87-9
| Post Date: |
May 07,2019 |
| Expiry Date: |
Nov 03,2019 |
| Detailed Description: |
Cas No. :135459-87-9
Strontium ranelate, a strontium(II) salt of ranelic acid, is a medication for osteoporosis. Studies indicate it can also slow the course of osteoarthritis of the knee. The drug is unusual in that it both increases deposition of new bone by osteoblasts and reduces the resorption of bone by osteoclasts. It is therefore promoted as a "dual action bone agent" (DABA). |
| CAS Registry Number: |
|
| Synonyms: |
;Distrontium renelate;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt;STRONCIUM RANELATE;5-[bis(carboxymethyl)amino]-3-(carboxymethyl)-4-cyanothiophene-2-carboxylic acid;strontium 5-[bis(carboxylatomethyl)amino]-3-(carboxylatomethyl)-4-cyanothiophene-2-carboxylate hydrate (2:1:7);Ranelate Strontium;5-[Bis(carboxymethyl)amino]-2-carboxy-4-cyano-3-thiopheneacetic acid strontium salt (1:2); |
| Molecular Formula: |
C12H20N2O15SSr2 |
| Molecular Weight: |
639.5966 |
| Molecular Structure: |
|
-
Disclaimer statement:The information and data included above have been realized by the enterprises and compiled by the staff, and are subject to change without notice to you. The Chemnet makes no warranties or representations whatsoever regarding the facticity, accuracy and validity of such information and data. In order to ensure your interest, we suggest you chose the products posted by our gold suppliers or VIP members.
